Fine-mapping and candidate gene investigation within the PARK10 locus

European Journal of Human Genetics

Volumn 17, Issue 3, 2009, Pages 336-343

  Haugarvoll, Kristoffer ^a,b   Toft, Mathias ^b   Skipper, Lisa ^a   Heckman, Michael G ^a   Crook, Julia E ^a   Soto, Alexandra ^a   Ross, Owen A ^a   Hulihan, Mary M ^a   Kachergus, Jennifer M ^a   Sando, Sigrid B ^b,c   White, Linda R ^b   Lynch, Timothy ^d,e   Gibson, J Mark ^f   Uitti, Ryan J ^a   Wszolek, Zbigniew K ^a   Aasly, Jan O ^b,c   Farrer, Matthew J ^a  

^a MAYO CLINIC   (United States)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^d MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^e UNIVERSITY COLLEGE DUBLIN   (Ireland)

^f ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; PEPTIDASE; UBIQUITIN SPECIFIC PEPTIDASE 24; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; IRELAND; MAJOR CLINICAL STUDY; MALE; NORWAY; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IRELAND; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; NORWAY; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 60749108349     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2008.187     Document Type: Article

References (28)

1. de Rijk MC, Launer LJ, Berger K et al: Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000; 54 (11 Suppl 5): S21-S23.
2. Hicks AA, Petursson H, Jonsson T et al: A susceptibility gene for late-onset idiopathic Parkinson's disease. Ann Neurol 2002; 52 549-555.
3. Li YJ, Scott WK, Hedges DJ et al: Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet 2002; 70: 985-993.
4. Haugarvoll K, Toft M, Ross OA et al: ELAVL4, PARK10, and the celts. Mov Disord 2007; 22: 585-587.
5. Li Y, Schrodi S, Rowland C, Tacey K, Catanese J, Grupe A: Genetic evidence for ubiquitin-specific proteases USP24 and USP40 as candidate genes for late-onset Parkinson disease. Hum Mutat 2006; 27: 1017-1023.
6. Li YJ, Deng J, Mayhew GM, Grimsley JW, Huo X, Vance JM: Investigation of the PARK10 gene in Parkinson disease. Ann Hum Genet 2007; 71 (Part 5): 639-647.
7. Noureddine MA, Qin XJ, Oliveira SA et al: Association between the neuron-specific RNA-binding protein ELAVL4 and Parkinson disease. Hum Genet 2005; 117: 27-33.
8. Oliveira SA, Li YJ, Noureddine MA et al: Identification of risk and age-at-onset genes on chromosome 1p in Parkinson disease. Am J Hum Genet 2005; 77: 252-264.
9. Maraganore DM, de Andrade M, Lesnick TG et al: High-resolution whole-genome association study of Parkinson disease. Am J Hum Genet 2005; 77: 685-693.
10. Myers RH: Considerations for genomewide association studies in Parkinson disease. Am J Hum Genet 2006; 78: 1081-1082.
11. Clarimon J, Scholz S, Fung HC et al: Conflicting results regarding the semaphorin gene (SEMA5A) and the risk for Parkinson disease. Am J Hum Genet 2006; 78: 1082-1084; author reply 1092-1094.
12. Elbaz A, Nelson LM, Payami H et al: Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: A large-scale international study. Lancet Neurol 2006; 5: 917-923.
13. Farrer MJ, Haugarvoll K, Ross OA et al: Genomewide association, Parkinson disease, and PARK10. Am J Hum Genet 2006; 78: 1084-1088; author reply 92-94.
14. Goris A, Williams-Gray CH, Foltynie T, Compston DA, Barker RA, Sawcer SJ: No evidence for association with Parkinson disease for 13 single-nucleotide polymorphisms identified by whole-genome association screening. Am J Hum Genet 2006; 78: 1088-1090; author reply 1092-1094.
15. Li Y, Rowland C, Schrodi S et al: A case-control association study of the 12 single-nucleotide polymorphisms implicated in Parkinson disease by a recent genome scan. Am J Hum Genet 2006; 78: 1090-1092; author reply 1092-1094.
16. Anderson LR, Betarbet R, Gearing M et al: PARK10 candidate RNF11 is expressed by vulnerable neurons and localizes to Lewy bodies in Parkinson disease brain. J Neuropathol Exp Neurol 2007; 66: 955-964.
17. Goodacre S, Helgason A, Nicholson J et al: Genetic evidence for a family-based Scandinavian settlement of Shetland and Orkney during the Viking periods. Heredity 2005; 95: 129-135.
18. Helgason A, Sigurethardottir S, Nicholson J et al: Estimating scandinavian and gaelic ancestry in the male settlers of Iceland. Am J Hum Genet 2000; 67: 697-717.
19. Fahn S, Elton RL, Members of the UPDRS development committee: Unified Parkinson's disease rating scale; in Fahn S, Marsden CD, Calne D, Goldstein M (eds):: Recent Development in Parkinson's Disease. Florham Park: Macmillan Health Care Information, 1987, pp 153-163.
20. Hoehn MMO Yahr MD: Parkinsonism: onset, progression, and mortality. 1967. Neurology 2001; 50: S11-S26.
21. Gelb DJ, Oliver E, Gilman S: Diagnostic criteria for Parkinson disease. Arch Neurol 1999; 56: 33-39.
22. BarreAt JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21 263-265.
23. Maniatis N, Collins A, Xu CF et al: The first linkage disequilibrium (LD) maps: Delineation of hot and cold blocks by diplotype analysis. Proc Natl Acad Sci USA 2002; 99: 2228-2233.
24. Westfall PH, Young SS: Resampling-Based Multiple Testing: Examples and Methods for P-value Adjustment. New York: John Wiley and Sons, 1993, pp 66.
25. Li YJ, Hauser MA, Scott WK et al: Apolipoprotein E controls the risk and age at onset of Parkinson disease. Neurology 2004; 62 2005-2009.
26. Chanock SJ, Manolio T, Boehnke M et al: Replicating genotypephenotype associations. Nature 2007; 447: 655-660.
27. Clarke GM, Carter KW, Palmer LJ, Morris AP, Cardon LR: Fine mapping versus replication in whole-genome association studies. Am J Hum Genet 2007; 81: 995-1005.
28. Kitada T, Asakawa S, Hattori N et al: Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392: 605-608.